BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 21319732)

  • 21. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides.
    Fei L; Ren L; Zaro JL; Shen WC
    J Drug Target; 2011 Sep; 19(8):675-80. PubMed ID: 21142649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell Penetrating Peptides for Chemical Biological Studies.
    Nakase I; Takeuchi T; Futaki S
    Methods Mol Biol; 2015; 1324():387-96. PubMed ID: 26202284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of cell-penetrating peptides as signal transduction modulators for the selective induction of apoptosis.
    Jones S; Howl J
    Methods Mol Biol; 2011; 683():291-303. PubMed ID: 21053138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
    Kibria G; Hatakeyama H; Harashima H
    Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transduction of peptides and proteins into live cells by cell penetrating peptides.
    Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
    J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery.
    Di Pisa M; Chassaing G; Swiecicki JM
    J Pept Sci; 2015 May; 21(5):356-69. PubMed ID: 25787823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.
    Mokhtarieh AA; Kim S; Lee Y; Chung BH; Lee MK
    Biochem Biophys Res Commun; 2013 Mar; 432(2):359-64. PubMed ID: 23384441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
    Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
    Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
    Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
    J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
    Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
    J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel system to achieve one-pot modification of cargo molecules with oligoarginine vectors for intracellular delivery.
    Takayama K; Tadokoro A; Pujals S; Nakase I; Giralt E; Futaki S
    Bioconjug Chem; 2009 Feb; 20(2):249-57. PubMed ID: 19161253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
    Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
    Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
    Mussbach F; Pietrucha R; Schaefer B; Reissmann S
    Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.